HomeNDRA • NASDAQ
add
ENDRA Life Sciences Inc
Previous close
$6.23
Day range
$5.50 - $6.18
Year range
$2.90 - $11.96
Market cap
6.89M USD
Avg Volume
90.17K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.37M | -9.17% |
Net income | -1.60M | 32.20% |
Net profit margin | — | — |
Earnings per share | -2.10 | 77.99% |
EBITDA | -1.36M | 9.19% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 794.04K | -83.27% |
Total assets | 1.96M | -76.56% |
Total liabilities | 1.79M | 1.03% |
Total equity | 171.38K | — |
Shares outstanding | 1.17M | — |
Price to book | 28.32 | — |
Return on assets | -143.63% | — |
Return on capital | -251.29% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -1.60M | 32.20% |
Cash from operations | -1.16M | 29.76% |
Cash from investing | 0.00 | — |
Cash from financing | 149.47K | 8,780.93% |
Net change in cash | -1.01M | 38.72% |
Free cash flow | -659.35K | 48.26% |
About
Founded
2008
Headquarters
Website
Employees
21
